CHRISTOPHER KALLINGER: Open Payments
NPI 1720520687 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,708 in 272 payments from 24 companies in 2025. Trend: 2023 $3,418 · 2024 $4,286 · 2025 $4,708
Food & beverage: $4,536Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $732 |
| Amgen Inc. | 32 | $633 |
| UCB, Inc. | 17 | $378 |
| Incyte Corporation | 17 | $377 |
| LEO Pharma Inc. | 13 | $266 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $262 |
| GENZYME CORPORATION | 11 | $228 |
| Galderma Laboratories, L.P. | 11 | $211 |
| Lilly USA, LLC | 17 | $206 |
| Regeneron Healthcare Solutions, Inc. | 11 | $202 |
Products named: OTEZLA, DUPIXENT, SKYRIZI, Bimzelx, OPZELURA, RINVOQ, ILUMYA, ADBRY.
Industry payments across FL — which companies pay providers there.
